Dr. Veech's ketone ester study for Parkinson's disease is now enrolling in Oxford, England, under the direction of Dr. Wesley Thevathasan at John Radcliffe Hospital. This is a short term study and twenty patients will be able to participate. The ketone ester previously passed human toxicity testing through the USAs FDA.
To learn more about this please look at www.clinicaltrials.gov
and do a search for "parkinson's and ketone ester" or enter the trial identifier "NCT01364545".
Labels: clinical trial, ketogenic diet, ketone ester, ketones, parkinson's